Toggle navigation
Home
Search
Services
Blog
Contact
About
Induction, Biological Markers and Therapy of Tumors
Dalgard, Daniel W.
Covance Laboratories, Inc., Vienna, VA, United States
Search 19 grants from Daniel Dalgard
Search grants from Covance Laboratories, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development of a Vaccine Approach to Inhibit Atherosclerosis
Effects of Opiates on Cellular Mechanisms
Knowledge Structures and Adult Intellectual Development
Thrombus Detection Using Fibrin-Specific Antibodies
Mortality From Neurologic Disorders - National and International Comparisons
Recently added grants:
Passive mobile sensing and machine learning for the detection of drinking episodes
Resolving differences between clinical opioids at single neurons
Sexual dimorphism, hepatic mitochondrial adaptations, and hepatic steatosis
Credentialing Delta-like 3 (DLL3) as an oncoprotein and immunotherapeutic target in neuroblastoma
Enhancing Physical Activity Adoption and Maintenance in Adults with Obesity by Understanding Motivation for Exercise: A Mixed Methods Research Design
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM025601-009
Application #
3609868
Study Section
Project Start
1981-11-01
Project End
1984-10-31
Budget Start
1985-02-20
Budget End
1984-10-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Covance Laboratories, Inc.
Department
Type
DUNS #
City
Vienna
State
VA
Country
United States
Zip Code
22182
Related projects
NIH 1986
N01 CM
Induction, Biological Markers and Therapy of Tumors
Dalgard, Daniel W. / Covance Laboratories, Inc.
NIH 1985
N01 CM
Induction, Biological Markers and Therapy of Tumors
Dalgard, Daniel W. / Covance Laboratories, Inc.
Comments
Be the first to comment on Daniel Dalgard's grant